Increasing pessimism about ‘return to normal’ by June from COVID-19 crisis, shows poll

People in Japan, the U.K. and Australia are most negative about a recovery by June.

The author(s)
  • Darrell Bricker Global Head of Public Affairs - Ipsos
Get in touch

Optimism over the coronavirus outbreak coming to an end in a few months has declined in most countries surveyed by Ipsos since March in the latest global poll.

In mid-March, majorities of people in most countries surveyed believed the COVID-19 crisis was a relatively short-term crisis which would be resolved by June, and life would return to normal.

This optimism has continuously declined in about half the countries polled since March 12-14 as citizens appear to be settling in for the long haul. In a survey of 28,000 people across 15 countries conducted from April 2 to 4, the respondents most negative about a recovery by June are in Japan (19%), the United Kingdom (27%), and Australia (32%).

On the other end, those most optimistic about a June recovery are in Vietnam (92%), Brazil (85%) and Mexico (84%).

The biggest change we have seen in opinions since mid-March about a June recovery have been in countries where optimism has declined. This is led by Canada down 25 percentage points, followed by France (-23), Italy, Japan and the U.K. (-22).

Overall, these findings show that in countries where there has been a large movement in opinion about a June recovery, the sentiment turned more negative than positive.

I expect things to return to normal by june | Ipsos | Coronavirus pandemic | covid-19 crisis | Global @dvisor

These are the results of an Ipsos survey conducted April 2nd to 4th, 2020 on the Global Advisor online platform among 28,000 adults aged 18-74 in Canada and the United States and 16-74 in Australia, Brazil, China, France, Germany, Italy, India, Japan, Mexico, Russia, Vietnam and the United Kingdom. Where available, tracking results from previous studies, conducted through March and selected results from February are referenced by date.
The author(s)
  • Darrell Bricker Global Head of Public Affairs - Ipsos

More insights about Health